A Network Analysis of COVID-19 MRNA Vaccine Patents
A preliminary network analysis highlights the complex intellectual property landscape behind mRNA-based COVID-19 vaccines.

Send us a link
A preliminary network analysis highlights the complex intellectual property landscape behind mRNA-based COVID-19 vaccines.
The publisher will launch five new journals, and has introduced a new business model that aims to spread the cost of publishing more fairly.
If you're starting a doctoral programme later this year, particularly if your institution is still facing COVID-19 restrictions, Ciara O'Brien has some advice.
The Swiss National Science Foundation hopes to eliminate bias when choosing between applications of similar quality.
Global South scientists say that an open-access movement led by wealthy nations deprives them of credit and undermines their efforts.
Governments that ignore or delay acting on scientific advice are missing out on a crucial opportunity to control the pandemic.
Many scientist couples move abroad together, but Gidiane Scaratti and Rafael Kenji Nishihora chose to live and work in different countries. This is what they learnt.
Universities, funders and others want to expand the contributions that the scientific community values and recognizes, says Karen Stroobants.
Big data bibliometrics must take into account qualitative analyses of research as a social institution, rooted in history, economics and politics.
Don't get bogged down in technical details, and balance the professional and the personal.
Rasha Shraim's education helped her to think more deeply about ethics, logic and other big questions.
Senior male researchers at prestigious institutions are the most likely to pay to publish open access, study suggests.
Kevin Boehnke and Richard E. Harris introduced a course in meditation, yoga and mindfulness to the neuroscience programme at their institution.
Early-career researchers bring energy, talent and diverse voices to leadership and advisory roles.
The push to remove journal paywalls officially started this year. Here's how it works.
Analysis reveals three ways to boost green investment and achieve a resilient recovery from the coronavirus pandemic.
As the National Institutes of Health begins implementing Trump-era guidelines, researchers voice concerns over transparency and racial profiling.
A treaty might help countries to prepare for the next pandemic - but first they must study what went wrong during this one.
The pandemic is being used as a pretext to push unproven artificial-intelligence tools into workplaces and schools.
Search-engine co-founder Anurag Acharya explains why it now tells authors when their papers should be made free to read.
The pandemic is not a competition between companies and will not end without more-equal distribution of coronavirus vaccines.
Scientists say the conclusions make sense but note that supporters of the lab-leak theory are unlikely to be satisfied.
Risks shoot up when virus particles accumulate in buildings, but it's not clear how best to improve ventilation.
A special report outlines the challenges - from unleashing the power of mRNA vaccines, to the battle for temporary intellectual-property relief.
Research software infrastructure is critical for accelerating science, and yet, these digital public goods are often unsustainably funded. Solving this problem requires an appreciation of the intrinsic value of research software outputs, and greater investment of time and effort into effectively funding maintenance of software at scale.
Critics say redundancies are being decided using unreliable measures related to funding and citations, highlighting broader unease about the use of metrics in science.
Results confirming the vaccine's strong protection against COVID-19 were welcomed following last week's pause in roll-outs - but fresh questions have now emerged about the data.
The three of us took a break from our PhD programmes for a stint that enriched our CVs and improved our chances of career success.